ETFs positioned on West Pharmaceutical Services, Inc.

Name Weight AuM 1st Jan change Investor Rating
2.21% 9 M€ -.--%
2.04% 5 M€ -1.80% -
1.44% 15 M€ -3.79%
1.02% 18 M€ +7.28% -
0.95% 2 M€ +16.70%
0.81% 1 M€ +2.21% -
0.80% 261 M€ +10.80%
0.59% 4,592 M€ -.--%
0.30% 2 M€ +20.44% -
0.27% 3,859 M€ +18.82%
0.27% 469 M€ -1.75%
0.27% 9 M€ -.--% -
0.19% 44 M€ -.--%
0.17% 5 M€ -72.95% -
0.16% 1,448 M€ -.--% -
0.15% 2,805 M€ +17.41%
0.15% 330 M€ -.--% -
0.15% 78 M€ +15.03%
0.15% 2 M€ +14.69% -
0.13% 11 M€ +11.17%
0.11% 322 M€ -.--%
0.11% 29 M€ -.--% -
0.11% 414 M€ +15.34% -
0.11% 1,006 M€ -.--% -
0.10% 270 M€ -.--% -
0.10% 209 M€ +14.54% -
0.10% 458 M€ -.--%
0.10% 36 M€ -.--%
0.10% 9 M€ +11.22% -
0.10% 754 M€ +12.51%
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Employees
10,600
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
302.03USD
Average target price
351.85USD
Spread / Average Target
+16.50%
Consensus
  1. Stock Market
  2. Equities
  3. WST Stock
  4. ETFs West Pharmaceutical Services, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW